Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference
Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12th at 9:00 AM EDT.
The company, a pioneer in the over-the-counter (OTC) self-care market, has over a century of experience providing health and wellness solutions in North America and Europe. Perrigo's business model combines store brand private label offerings with leading brands including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
Perrigo (NYSE: PRGO), un importante fornitore di Prodotti per l'Auto-Cura dei Consumatori, ha annunciato che il Presidente e CEO Patrick Lockwood-Taylor e il CFO Eduardo Bezerra parteciperanno alla Canaccord Genuity 45th Annual Growth Conference martedì 12 agosto alle 9:00 AM EDT.
L'azienda, pioniera nel mercato dei prodotti da banco (OTC) per l'auto-cura, vanta oltre un secolo di esperienza nella fornitura di soluzioni per la salute e il benessere in Nord America ed Europa. Il modello di business di Perrigo combina offerte di marche private per negozi con marchi leader come Opill®, Mederma®, Compeed®, EllaOne® e Jungle Formula®.
Perrigo (NYSE: PRGO), un proveedor líder de Productos de Autocuidado para Consumidores, anunció que el Presidente y CEO Patrick Lockwood-Taylor y el CFO Eduardo Bezerra presentarán en la Canaccord Genuity 45th Annual Growth Conference el martes 12 de agosto a las 9:00 AM EDT.
La empresa, pionera en el mercado de autocuidado de venta libre (OTC), cuenta con más de un siglo de experiencia proporcionando soluciones de salud y bienestar en Norteamérica y Europa. El modelo de negocio de Perrigo combina ofertas de marcas privadas para tiendas con marcas líderes como Opill®, Mederma®, Compeed®, EllaOne® y Jungle Formula®.
Perrigo (NYSE: PRGO)는 소비자 자가 관리 제품의 선도적인 공급업체로서, 대표이사 겸 CEO 패트릭 록우드-테일러와 CFO 에두아르도 베제라가 8월 12일 화요일 오전 9시(EDT)에 열리는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에서 발표할 예정임을 발표했습니다.
이 회사는 일반의약품(OTC) 자가 관리 시장의 선구자로서, 북미와 유럽에서 건강 및 웰빙 솔루션을 제공한 100년 이상의 경험을 보유하고 있습니다. Perrigo의 비즈니스 모델은 매장 브랜드의 프라이빗 라벨 제품과 Opill®, Mederma®, Compeed®, EllaOne®, Jungle Formula®와 같은 주요 브랜드를 결합하고 있습니다.
Perrigo (NYSE : PRGO), un fournisseur majeur de produits d'autosoins pour les consommateurs, a annoncé que le Président-directeur général Patrick Lockwood-Taylor et le Directeur financier Eduardo Bezerra présenteront lors de la Canaccord Genuity 45th Annual Growth Conference, le mardi 12 août à 9h00 EDT.
L'entreprise, pionnière sur le marché des produits d'autosoins en vente libre (OTC), bénéficie de plus d'un siècle d'expérience dans la fourniture de solutions de santé et de bien-être en Amérique du Nord et en Europe. Le modèle commercial de Perrigo combine des offres de marques de distributeur avec des marques leaders telles que Opill®, Mederma®, Compeed®, EllaOne® et Jungle Formula®.
Perrigo (NYSE: PRGO), ein führender Anbieter von Consumer Self-Care-Produkten, gab bekannt, dass Präsident und CEO Patrick Lockwood-Taylor sowie CFO Eduardo Bezerra auf der Canaccord Genuity 45th Annual Growth Conference am Dienstag, den 12. August um 9:00 Uhr EDT präsentieren werden.
Das Unternehmen, ein Pionier im Markt für rezeptfreie (OTC) Selbstpflegeprodukte, verfügt über mehr als ein Jahrhundert Erfahrung in der Bereitstellung von Gesundheits- und Wellnesslösungen in Nordamerika und Europa. Das Geschäftsmodell von Perrigo kombiniert Eigenmarkenangebote mit führenden Marken wie Opill®, Mederma®, Compeed®, EllaOne® und Jungle Formula®.
- None.
- None.
Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord Genuity 45th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.
Perrigo Contact
Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com
Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-present-at-the-canaccord-genuity-45th-annual-growth-conference-302515980.html
SOURCE Perrigo Company plc